Form 4: Arteris Insider Sells Shares Under 10b5-1 Plan

Bayview Legacy, LLC, an entity associated with Arteris, Inc. director K. Charles Janac, has reported the sale of common stock valued at approximately $2.8 million under a pre-arranged trading plan.

Summary

• Bayview Legacy, LLC, managed by K. Charles Janac, sold a total of 213,095 shares of Arteris, Inc. common stock on July 2, 2026.
• These sales were executed under a Rule 10b5-1 trading plan adopted on December 12, 2025.
• The sales occurred at weighted average prices ranging from $34.20 to $43.51 per share.
• The total proceeds from these sales amount to approximately $2,800,000.
• K. Charles Janac, as manager of Bayview Legacy, LLC, is deemed to have beneficial ownership of these shares and has also filed a separate Form 4 reporting the same transactions.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a slightly negative filing due to the significant sale of shares by an affiliated entity of a director, despite being executed under a 10b5-1 plan.

Negatives

• Significant sale of shares by a director's affiliated entity, potentially signaling a lack of confidence or a need for liquidity.

Risks

• The sale of a substantial number of shares by an insider could be interpreted negatively by the market, potentially impacting the stock price.
• While executed under a 10b5-1 plan, large sales can still create downward pressure on the stock.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports past transactions.

Management Comments

• The transactions were made pursuant to a 10b5-1 trading plan adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC.
• K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

Industry Context

StockSavvy.ai notes that insider selling, even under a pre-arranged 10b5-1 plan, is a common event in the semiconductor IP sector. Investors often scrutinize these sales for potential signals about management's view of the company's valuation and future prospects.

Related Party Transactions

• The transactions involve Bayview Legacy, LLC, an entity managed by K. Charles Janac, who is a director of Arteris, Inc. K. Charles Janac is also reporting the same transactions in his individual capacity due to his beneficial ownership through Bayview Legacy, LLC.

Stakeholder Impact

• Shareholders may view the sale of a large block of shares by an insider's affiliated entity with concern, potentially leading to short-term stock price pressure.
• Employees with stock options or grants may be affected by any negative market reaction to the insider sale.

Key Dates

Recommendation

While the sale by an insider's affiliated entity under a 10b5-1 plan is a negative signal, it is a pre-planned transaction and does not necessarily reflect new negative information about the company's fundamental performance. A 'hold' recommendation is appropriate pending further developments or clarification.

Keywords

Arteris Inc, AIP, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, K. Charles Janac, Bayview Legacy, LLC